Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
sumatriptan
|
| gptkbp:approvalYear |
1992
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N02CC01
|
| gptkbp:brand |
sumatriptan
|
| gptkbp:contraindication |
ischemic heart disease
uncontrolled hypertension |
| gptkbp:drugClass |
triptan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glaxo (Sumatriptan)
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Glaxo
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
subcutaneous injection nasal |
| gptkbp:sideEffect |
nausea
dizziness drowsiness flushing |
| gptkbp:usedFor |
migraine
cluster headache |
| gptkbp:bfsParent |
gptkb:Triptans
|
| gptkbp:bfsLayer |
7
|